Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

CHRISTOPHER SR DAKHIL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1972721348
CMS profile
44029
Location
WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$6,404.97

141 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Paying entityAmountRecords
Daiichi Sankyo Inc. $1,582.75 5
Novartis Pharmaceuticals Corporation $1,151.28 20
Karyopharm Therapeutics Inc. $789.18 3
Verity Pharmaceuticals Inc. $500.00 1
Athenex Pharmaceutical Division, LLC $350.00 2
AstraZeneca Pharmaceuticals LP $248.29 6
GENZYME CORPORATION $159.09 6
ARRAY BIOPHARMA INC $136.80 8
Epizyme, Inc., $96.85 6
Amgen Inc. $92.84 6
PFIZER INC. $81.28 5
US Oncology Corporate, Inc. $69.93 1
Genentech USA, Inc. $69.34 5
TerSera Therapeutics LLC $64.80 3
EMD Serono, Inc. $61.11 4
Celgene Corporation $55.61 3
MorphoSys, US Inc. $52.01 1
GlaxoSmithKline, LLC. $45.20 3
Astellas Pharma US Inc $44.99 3
Seagen Inc. $44.89 3
Merck Sharp & Dohme Corporation $44.77 3
Pharmacyclics LLC, An AbbVie Company $44.68 3
Kite Pharma, Inc. $44.47 3
Acrotech Biopharma LLC $39.83 3
E.R. Squibb & Sons, L.L.C. $38.68 3
SUN PHARMACEUTICAL INDUSTRIES INC. $35.02 2
Takeda Pharmaceuticals U.S.A., Inc. $32.38 2
Eisai Inc. $30.79 2
Janssen Biotech, Inc. $29.56 2
Gilead Sciences, Inc. $25.90 2
BeiGene USA, Inc. $24.64 2
Dova Pharmaceuticals $23.92 2
Ipsen Biopharmaceuticals, Inc $23.50 1
AbbVie Inc. $20.40 1
Boehringer Ingelheim Pharmaceuticals, Inc. $20.07 1
JAZZ PHARMACEUTICALS INC. $19.43 1
Taiho Oncology, Inc. $19.40 1
Regeneron Healthcare Solutions, Inc. $18.93 1
Mylan Institutional Inc. $17.92 1
Myovant Sciences Inc. $17.24 1
Foundation Medicine, Inc. $16.13 1
Lilly USA, LLC $15.55 1
Blueprint Medicines Corporation $14.88 1
Rigel Pharmaceuticals, Inc. $14.22 1
Global Blood Therapeutics, Inc. $13.98 1
PUMA BIOTECHNOLOGY, INC. $13.44 1
Exelixis Inc. $12.91 1
ARBOR PHARMACEUTICALS, INC. $12.67 1
Bayer HealthCare Pharmaceuticals Inc. $12.00 1
Kyowa Kirin, Inc. $11.42 1

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

CHRISTOPHER SR DAKHIL

NPI 1972721348 · CMS profile ID 44029

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

WICHITA, KS

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1972721348?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1972721348?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1972721348?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
CHRISTOPHER SR DAKHIL, NPI 1972721348, CMS profile ID 44029, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 141 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1972721348?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

141 matching records · $6,404.97 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 141 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 141.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Kite Pharma, Inc. $14.0108/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844412363 CMS
TerSera Therapeutics LLC $24.8108/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851043957 CMS
Novartis Pharmaceuticals Corporation $99.7008/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649743 CMS
E.R. Squibb & Sons, L.L.C. $12.1908/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783647575 CMS
Celgene Corporation $20.6308/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783729059 CMS
Novartis Pharmaceuticals Corporation $18.1508/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649721 CMS
AstraZeneca Pharmaceuticals LP $107.5808/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829907673 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.0707/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 763755028 CMS
GENZYME CORPORATION $8.9907/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843629267 CMS
Kite Pharma, Inc. $14.9107/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 844412361 CMS
AstraZeneca Pharmaceuticals LP $14.4307/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830092685 CMS
Myovant Sciences Inc. $17.2407/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834950293 CMS
US Oncology Corporate, Inc. $69.9307/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 823639707 CMS
Genentech USA, Inc. $15.6507/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835897585 CMS
Seagen Inc. $17.3907/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832179241 CMS
ARRAY BIOPHARMA INC $21.7007/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833099805 CMS
GENZYME CORPORATION $22.5507/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843629263 CMS
Dova Pharmaceuticals $11.2007/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849748315 CMS
MorphoSys, US Inc. $52.0107/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 854737149 CMS
PFIZER INC. $11.7207/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833102085 CMS
AstraZeneca Pharmaceuticals LP $12.8206/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829860127 CMS
BeiGene USA, Inc. $11.6306/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 846697997 CMS
AstraZeneca Pharmaceuticals LP $21.8906/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829610833 CMS
Novartis Pharmaceuticals Corporation $16.8606/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649717 CMS
Novartis Pharmaceuticals Corporation $99.7006/16/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649741 CMS
Seagen Inc. $14.0806/14/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832179209 CMS
Pharmacyclics LLC, An AbbVie Company $16.3306/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 781009291 CMS
Kyowa Kirin, Inc. $11.4206/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 852983549 CMS
PFIZER INC. $13.8006/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833101045 CMS
E.R. Squibb & Sons, L.L.C. $12.0606/01/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 783647545 CMS
Gilead Sciences, Inc. $11.9206/01/2021 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845872173 CMS
GENZYME CORPORATION $19.2605/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843629245 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $15.3705/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851870579 CMS
Exelixis Inc. $12.9105/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 838868711 CMS
Merck Sharp & Dohme Corporation $14.8405/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848477631 CMS
Novartis Pharmaceuticals Corporation $99.7005/14/2021 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649739 CMS
Mylan Institutional Inc. $17.9205/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 965335991 CMS
ARRAY BIOPHARMA INC $20.1305/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833100293 CMS
PUMA BIOTECHNOLOGY, INC. $13.4405/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 834086053 CMS
Seagen Inc. $13.4205/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832179175 CMS
Genentech USA, Inc. $15.2405/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 835897579 CMS
Gilead Sciences, Inc. $13.9804/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848182301 CMS
Merck Sharp & Dohme Corporation $14.6304/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848559693 CMS
Karyopharm Therapeutics Inc. $17.4604/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845784175 CMS
Novartis Pharmaceuticals Corporation $7.2104/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812649719 CMS
Lilly USA, LLC $15.5504/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819026557 CMS
Foundation Medicine, Inc. $16.1304/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 799849867 CMS
Merck Sharp & Dohme Corporation $15.3004/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848325659 CMS
TerSera Therapeutics LLC $16.6604/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851043955 CMS
Amgen Inc. $15.1204/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 826529513 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $6,186.95 149
PY2020 $6,168.70 101
PY2021 $6,404.97 141
PY2022 $13,209.82 175
PY2023 $18,215.72 191
PY2024 $4,814.36 190
PY2025 $4,078.06 166

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2022 Recipient $1,536.87 1
PY2022 Principal investigator $15,607.00 5
PY2021 Principal investigator $4,600.00 1
PY2019 Principal investigator $34,271.25 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

6 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $3,500.00 09/19/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757193
Principal investigator 1 PFIZER INC. $1,275.00 08/22/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757135
Principal investigator 1 PFIZER INC. $1,275.00 08/22/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
PATINAA RANDOMIZED OPEN LABEL PHASE III TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PALBOCICLIB ANTIHER2 THERAPY ENDOCRINE THERAPY VS ANTIHER2 THERAPY ENDOCRINE THERAPY AFTER INDUCTION TREATMENT FOR HRHER2 METASTATIC BREAST CANCER No dispute reported 06/30/2026 949757137
Principal investigator 1 PFIZER INC. $2,477.00 06/21/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY EXTENSIVESTAGE SMALL CELL LUNG CANCER TRIOUS L07 No dispute reported 06/30/2026 949805437
Recipient F. Hoffmann-La Roche AG $1,536.87 03/31/2022 Covered Recipient Physician A PHASE II SINGLE-ARM STUDY OF ATEZOLIZUMAB MONOTHERAPY IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER CLINICAL EVALUATION OF NOVEL BLOOD-BASED DIAGNOSTICS No dispute reported 06/30/2026 950635685
Principal investigator 1 PFIZER INC. $7,080.00 02/01/2022 Non-covered Recipient Entity
Cancer Center of Kansas PA
A PHASE 2 STUDY OF CONTINUOUS TALAZOPARIB PLUS INTERMITTENT LOWDOSE TEMOZOLOMIDE IN PATIENTS WITH RELAPSED OR REFRACTORY EXTENSIVESTAGE SMALL CELL LUNG CANCER TRIOUS L07 No dispute reported 06/30/2026 949804953